These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27577110)

  • 21. [Treatment outcome of immune thrombocytopenia].
    Iványi JL; Marton E; Plander M
    Orv Hetil; 2012 Oct; 153(41):1613-21. PubMed ID: 23045311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of adult idiopathic thrombocytopenic purpura.
    Nakhoul IN; Kozuch P; Varma M
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An analysis of outcomes and treatment costs for children undergoing splenectomy for chronic immune thrombocytopenia purpura.
    Gwilliam NR; Lazar DA; Brandt ML; Mahoney DH; Wesson DE; Mazziotti MV; Nuchtern JG; Lee TC
    J Pediatr Surg; 2012 Aug; 47(8):1537-41. PubMed ID: 22901913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second-line treatment trends and long-term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years.
    Ducassou S; Gourdonneau A; Fernandes H; Leverger G; Pasquet M; Fouyssac F; Bayart S; Bertrand Y; Michel G; Jeziorski E; Thomas C; Abouchallah W; Viard F; Guitton C; Cheikh N; Pellier I; Carausu L; Droz C; Leblanc T; Aladjidi N;
    Br J Haematol; 2020 Jun; 189(5):931-942. PubMed ID: 32130726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of platelet recovery in ITP associated with therapy.
    Pang SJ; Lazarus AH
    Ann Hematol; 2010 Jul; 89 Suppl 1():31-5. PubMed ID: 20179926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current therapies in primary immune thrombocytopenia.
    Pels SG
    Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association of rituximab and a thrombopoietin receptor agonist in high-risk refractory immune thrombocytopenic purpura.
    Veneri D; Soligo L; Pizzolo G; Ambrosetti A
    Blood Transfus; 2015 Oct; 13(4):694-5. PubMed ID: 26057496
    [No Abstract]   [Full Text] [Related]  

  • 28. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center.
    Zimmer J; Andrès E; Noel E; Koumarianou A; Blicklé JF; Maloisel F
    Clin Lab Haematol; 2004 Apr; 26(2):137-42. PubMed ID: 15053808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Updated guidelines for immune thrombocytopenic purpura: Expanded management options.
    DeSouza S; Angelini D
    Cleve Clin J Med; 2021 Dec; 88(12):664-668. PubMed ID: 34857604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Idiopathic thrombocytopenic purpura (ITP) in children].
    Rajantie J
    Duodecim; 2011; 127(19):2081-6. PubMed ID: 22073540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of the novel thrombopoietin receptor-agonist romiplostim, in combination with steroids and immunoglobulins for the increase of platelets prior to splenectomy, in refractory immune thrombocytopenia: a case report.
    Sivera P; Ruella M; Gueli A; Hu H; Wade M; Tarella C
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):331-4. PubMed ID: 22343685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune thrombocytopenic purpura--the changing therapeutic landscape.
    Bromberg ME
    N Engl J Med; 2006 Oct; 355(16):1643-5. PubMed ID: 17050888
    [No Abstract]   [Full Text] [Related]  

  • 33. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis and therapy of autoimmune thrombocytopenia. Recommendations of a joint Expert Group of DGHO, DGTI, DTH].
    Matzdorff A; Giagounidis A; Greinacher A; Hiller E; Kiefel V; Müller-Beissenhirtz H; Ostermann H; Rummel M; Sachs UJ; Salama A
    Onkologie; 2010; 33 Suppl 3():2-20. PubMed ID: 20484949
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful treatment of immune thrombocytopenic purpura (ITP) with splenectomy.
    Ortega Deballon P; Alonso García MT; Moreno Azcoita M
    World J Surg; 2001 Feb; 25(2):251. PubMed ID: 11338029
    [No Abstract]   [Full Text] [Related]  

  • 36. [Splenectomy in immune thrombocytopenia and other hematological diseases].
    Lanzi S; Lancini GP; Piardi T; Biasca F; Ottaviani GM; Rossi G; Pizzoccaro C; Pouchè A
    G Chir; 1999; 20(11-12):479-86. PubMed ID: 10645065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of idiopathic thrombocytopenic purpura in adults].
    Godeau B; Bierling P
    Presse Med; 2008 Sep; 37(9):1292-8. PubMed ID: 18644317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immune thrombocytopenic purpura: pathophysiology and treatment].
    Godeau B
    Transfus Clin Biol; 2009 May; 16(2):101-5. PubMed ID: 19409827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of various treatments in the management of idiopathic thrombocytopenic purpura in the adult].
    Llamas P; Busto MJ; Díez JL; Cabrera R; Regidor C; Forés R; Sanjuán I; Briz M; Fernández MN
    Sangre (Barc); 1995 Jun; 40(3):181-5. PubMed ID: 7570269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current and emerging treatments for immune thrombocytopenia.
    Dou X; Yang R
    Expert Rev Hematol; 2019 Sep; 12(9):723-732. PubMed ID: 31237783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.